Table I.
IC50 in MCF7 cells | IC50 in PC3 cells | |||||
---|---|---|---|---|---|---|
Treatment agent | 24 h | 48 h | 72 h | 24 h | 48 h | 72 h |
Aqueous fraction | >100 | >100 | >100 | >100 | >100 | >100 |
Methanolic extract | >100 | 64.64±1.64 | 93.47±5.11 | >100 | 70.33±2.36 | 95.82±1.96 |
CH2Cl2 fraction | 22.17±2.33a | 25.34±2.01b | 43.15±3.02a | 58.01±6.39 | 37.97±3.87 | 72.39±6.84 |
Ethyl acetate fraction | 42.38±2.54b | 35.2±2.69a | 55.38±4.25a | 72.37±3.69 | 51.57±3.89 | 73.22±3.64 |
Essential oil | 21.17±2.01b | 12.55±3.65c,d | 31.35±3.69 | 43.65±4.12 | 22.25±4.25e | 39.91±3.21 |
Paclitaxel (positive control) | 6.34±0.81a | 3.45±0.39a | 6.75±0.57a | 0.10±0.02 | 0.09±0.03 | 0.08±0.03 |
The IC50 values were quantified by MTT assay. The data are presented as the means ± standard deviation (n=5). Letters (d-f) are an indicator of statistical differences obtained separately between essential oil and palitaxel (
P<0.05 and
P<0.001) after 48 h of exposure (most effective time point) and letters (a-c) are an indicator of statistical differences obtained separately for the MCF7 cell line compared to the PC3 cell line at each time point (
P<0.05,
P<0.01 and
P<0.001). CH2Cl2, dichloromethane.